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Activity-based probeCovalent conjugation of the small ubiquitin-like modiﬁer (SUMO) to proteins is a highly dynamic and revers-
ible process. Cells maintain a ﬁne-tuned balance between SUMO conjugation and deconjugation. In response
to stress stimuli such as heat shock, this balance is altered resulting in a dramatic increase in the levels of
SUMO conjugates. Whether this reﬂects an activation of the conjugation cascade, a decrease in the activity
of SUMO-speciﬁc proteases (SENPs), or both, remains unknown. Here, we show that from the ﬁve human
SENPs detected in HeLa cells (SENP1/2/3/6/7) the activities of all but one (SENP6) were largely diminished
after 30 min of heat shock. The decreased activity is not due to changes in their steady-state levels. Rather,
in vitro experiments suggest that these SENPs are intrinsically heat-sensitive, a property most likely emerging
from their catalytic domains. Heat shock inactivation seems to be a speciﬁc property of SENPs because nu-
merous members of the related deubiquitinase family of cysteine proteases are not affected by this stress
condition. Overall, our results suggest that SENPs are particularly sensitive to heat shock, a property that
may be important for the adaptation of cells to this stress condition.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Covalent modiﬁcation of proteins with the small ubiquitin-like
modiﬁer (SUMO) has been implicated in a wide variety of biological
processes such as DNA repair, transcription regulation, chromosome
structure and function, and signal transduction pathways (reviewed
in [1–3]). SUMO is ubiquitous in the eukaryotic kingdom [4–8].
Lower eukaryotes, such as yeasts and fungi, express only one SUMO
whereas higher organisms can have several paralogs (e.g., eight in
Arabidopsis thaliana [9]). Mammals express three of these proteins—
SUMO1/2/3 [5–7] which can be divided into two structural and func-
tional groups. One group comprises SUMO1 alone. The other encom-
passes the almost identical and functionally indistinguishable SUMO2
and SUMO3 [10,11].
Conjugation of SUMO to proteins involves an enzymatic cascade
comprising a SUMO-activating enzyme (E1) [12], a SUMO-conjugating
enzyme (UBC9) [13] and, at least in some cases, a SUMO ligase (E3;IMAC, immobilized metal ion
NP, SUMO-speciﬁc protease;
-like modiﬁer; Ub, ubiquitin;
r e Celular (IBMC), Universidade
rtugal. Tel.: +351 226074900;
l rights reserved.e.g., PIAS, RanBP2, TOPORS andPc2 [14–17]). Similarly to ubiquitination,
proteins can be modiﬁed with a single SUMO or with a chain of SUMO
molecules, modiﬁcations that probably have different biological out-
comes [1,11,18].
Protein SUMOylation is a highly dynamic and reversible process.
Reversibility is ensured by a small family of SUMO-speciﬁc proteases,
the so-called SENPs. SENPs are cysteine proteases containing a typical
His-Asp-Cys catalytic triad [19]. They are involved in processing precur-
sor forms of SUMO (endopeptidase activity) and in removing SUMO or
SUMO chains frommodiﬁed proteins (isopeptidase activity). Mammals
possess six of these proteases (SENP1–3 and 5–7), which can be phylo-
genetically organized into three groups [19–21]. The ﬁrst group com-
prises SENP1 and SENP2, two proteases with a robust endopeptidase
activity, although they also display some isopeptidase activity [22–27].
SENP3 and SENP5 belong to the second group and display mainly
isopeptidase activity [28–30]. The last group comprises SENP6 and
SENP7, two proteins that possess a strong isopeptidase activity on
polySUMO chains [31–34]. With the exception of SENP1, all other
SENPs seem to display a high paralog preference toward SUMO2/3
over SUMO1 [3,35,36].
Cells maintain a ﬁne-tuned balance between SUMO conjugation and
deconjugation. Under normal physiological conditions most SUMO1 is
found in a conjugated formwhereas SUMO2/3 aremostly unconjugated
[10]. Interestingly, the SUMO conjugation/deconjugation balance is
altered in several human diseases including cancer, neurodegenerative
disorders and heart disease, a ﬁnding that has fueled intensive research
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when cells are exposed to stress stimuli such as heat shock, oxidative
stress or alcohol treatment [10,39,40]. Under these conditions there is
a rapid shift of most SUMO2/3 from the unconjugated to the conjugated
form [10,41]. The system-wide SUMOylation alterations induced by
these stimuli are particularly well characterized in the case of heat
shock. Indeed, hundreds of proteins, many of which are involved in
stress resistance and damage repair, have been shown to be modiﬁed
by SUMO2/3 in response to this stimulus [42,43]. The ultimate result
of such a modiﬁcation is probably several-fold. For some proteins
polySUMOylation may promote polyubiquitination by the SUMO-
targeted ubiquitin ligase RNF4 leading to their subsequent degradation
by the proteasome (e.g., PARP-1 [44]). In other cases, SUMOylationmay
regulate protein activity/localization by creating or destroying protein
interaction interfaces [1,3,45,46]. Another possible outcome of
SUMOylation may be just an increase in the solubility of the targeted
protein [47–50].
Themechanisms behind themassive heat shock-induced accumula-
tion of SUMOylated proteins remain unknown. In principle, such a phe-
nomenon could result from an activation of the SUMO-conjugation
cascade, a decrease in the activities of SENPs, or a combination of
both. In this work we addressed the possible contribution of SENPs for
this phenomenon. We found that the majority of human SENPs are
inactivated upon heat shock.
2. Materials and methods
2.1. Plasmids and protein production
The bacterial expression plasmids encoding SUMO2 (UniProt acces-
sion number P61956) and the SUMO-conjugation cascade components
SAE1/SAE2 (E1) and Ubc9were kindly provided by Dr. FraukeMelchior
[51,52] and were used to obtain the respective recombinant proteins as
described [53].
Plasmids encoding untagged SUMO1or SUMO2 fused to intein and a
chitin-binding domain was obtained by replacing the hemagglutinin–
ubiquitin encoding sequence (HA-Ub) in the pTYB-HAUb plasmid (a
kind gift from Dr. Hidde Ploegh) [54] with one encoding SUMO1
(obtained from Mr. Gene) or SUMO2. A plasmid encoding untagged
ubiquitin, pTYB-Ub, was generated by digestion of pTYB-HAUb with
NdeI to remove the sequence coding for HA, followed by vector
religation. The pTYB-SUMO1/SUMO2/Ub constructs were used to pre-
pare untagged SUMO1/SUMO2/Ub-aldehyde according to [54,55].
Plasmids pTYB-HA-SUMO1/SUMO2 were obtained by inserting an
HA encoding sequence into the NdeI site of pTYB-SUMO1/SUMO2
constructs, respectively. The pTYB-HA-SUMO1/SUMO2/Ub plasmids
were used to produce HA-tagged SUMO1/SUMO2/Ub-vinyl methyl
ester (VME), as described [54], except that the ion-exchange puriﬁca-
tion step was omitted.
The cDNAs encoding SENP1 and SENP3 were ampliﬁed by RT-PCR
using total RNA from human ﬁbroblasts and cloned into the NheI/EcoRI
and NdeI/BamHI sites, respectively, of pET-28a vector. The SENP2 cDNA
was ampliﬁed using a pET-SENP2 plasmid as a template (a kind gift
from Dr. Keith Wilkinson) [35] and inserted into the NdeI/EcoRI sites of
the pET-28a vector. The cDNAs encoding SENP5/6/7 were ampliﬁed
using as templates pDONR221-SENP5 (PlasmID repository; clone ID
HsCD00039689), pENTR223-SENP6 (PlasmID repository; clone ID
HsCD00378900) and pCR-BluntII-TOPO-SENP7 (PlasmID repository;
clone ID HsCD00347824), respectively. The ampliﬁed DNA fragments
were inserted into the NdeI/XhoI (SENP5 and SENP7) or NheI/BamHI
(SENP6) sites of the pET-28a vector. 35S-labeled full-length SENP1–3/
5–7 were synthesized using these pET-28a-based plasmids and the
TNT® T7 Quick Coupled Transcription/Translation System (Promega) in
the presence of EasyTag™ L-[35S]-Methionine (Perkin Elmer, speciﬁc
activity >1000 Ci (37.0 TBq)/mmol), following the manufacturer's
instructions.Bacterial expression vectors encoding the catalytic domains of
SENP1/2/5/6/7 (cSENPs) were kindly provided by Dr. Guy Salvesen,
and were used to obtain the respective recombinant proteins, as
described [24]. For the SYPRO Orange ﬂuorimetric assays (see
below), cSENPs were puriﬁed using a two-step procedure. In the
ﬁrst step, cSENP1/2 were subjected to immobilized metal ion afﬁnity
chromatography (IMAC) puriﬁcation using HIS-Select™ nickel afﬁni-
ty gel (Sigma) and eluted in 50 mM Tris–HCl, pH 8.0, 150 mM NaCl,
10% (w/v) glycerol and 200 mM imidazole. Recombinant cSENP5–7
were was puriﬁed by IMAC using a TALON metal afﬁnity resin
(Clontech) and eluted with 50 mM Tris–HCl, pH 8.0, 350 mM NaCl,
10% (w/v) glycerol and 150 mM imidazole. In the second step,
cSENP1/2/5 were dialyzed against 50 mM Tris–HCl, pH 8.0, 150 mM
NaCl, 10% (w/v) glycerol and 0.5 mM DTT and further puriﬁed by
size-exclusion chromatography using a Superose 12 column HR 10/30
(GE Healthcare) running with the same buffer. IMAC-puriﬁed cSENP6
was diluted three-fold in 50 mM Tris–HCl, pH 8.0, 10% (w/v) glycerol
and 0.5 mM DTT, applied to a 1-ml HiTrap Q HP (GE Healthcare)
anion exchange column, and eluted with a 15-ml linear gradient of
150–575 mM NaCl in 50 mM Tris–HCl, pH 8.0, 10% (w/v) glycerol and
0.5 mM DTT. IMAC-puriﬁed cSENP7 was dialyzed against 50 mM Tris–
HCl, pH 8.0, 50 mM NaCl, 10% (w/v) glycerol and 0.5 mM DTT and pu-
riﬁed by anion exchange chromatography as above but using a
50–525 mM NaCl linear gradient instead. Puriﬁed cSENPs were
aliquoted, frozen in liquid N2 and stored at−80 °C.
2.2. Cell culture
HeLa cells were grown at 37 °C in the presence of 5% CO2 in a stan-
dard Dulbecco's modiﬁed Eagle's medium supplemented with 10%
heat-inactivated fetal bovine serum, 1% penicillin/streptomycin, 1%
L-glutamine, 1% fungyzone and 1% kanamycin. In heat shock experi-
ments, cells at 80% conﬂuence were harvested with a cell scraper,
resuspended in supplemented medium and incubated at 37 °C or
43 °C in awater bath for 30 min, unless otherwise indicated. In recovery
experiments, heat-shocked cells were transferred to Petri dishes and
allowed to recover at 37 °C in a CO2 incubator for the indicated periods
of time, either in the absence or presence of cycloheximide and puromy-
cin (30 μg/ml each). To prepare total cell lysates, cells were collected,
washed three times with phosphate-buffered saline, and centrifuged
at 2000×g for 10 min at 4 °C. Pellets were resuspended in SEM buffer
(0.25 M sucrose, 20 mM MOPS-KOH, pH 7.4, 1 mM EDTA-NaOH, pH
8.0) supplemented with protease inhibitors cocktail (Sigma) and
containing either 1 mMDTT or 10 mMN-ethylmaleimide (NEM), as in-
dicated. Total cell lysates were prepared by sonication, aliquoted, frozen
in liquid N2 and stored at−80 °C.
2.3. 7-Amino-4-methyl coumarin (AMC) activity assays
Determination of SENP activity in total HeLa cell homogenates
using SUMO1-AMC and SUMO2-AMC substrates (Enzo Life Sciences)
were performed essentially as described [35,56]. Brieﬂy, 50 μg of ex-
tracts from control or heat-shocked HeLa cells were incubated with
500 nM of AMC substrates in 140 μl of assay buffer (50 mM Tris–
HCl, pH 7.5, 0.1 mg/ml bovine serum albumin and 10 mM DTT). Hy-
drolysis of the substrates was measured by determining the increase
in ﬂuorescence (λex=340 nm and λem=440 nm) using a Horiba
FluoroMax-4 ﬂuorimeter.
2.4. SENP activity assays using SUMOylated rat liver nuclei proteins
Highly pure nuclei were prepared from rat liver total homoge-
nates by the method of Blobel and Potter, essentially as described
[57–59]. SUMOylated substrates were prepared by incubating
100 μg of puriﬁed nuclei with 50 nM SUMO E1, 100 nM Ubc9, 1 μM
SUMO2 and 2 mM ATP for 30 min at 43 °C. The SUMO-conjugation
Fig. 1. SENP activity in HeLa cells decreases upon heat shock. A) Total homogenates
from HeLa cells grown at 37 °C or heat-shocked at 43 °C for 30 min were incubated
with either SUMO1-AMC (S1-AMC) or SUMO2-AMC (S2-AMC). Activities were deter-
mined ﬂuorimetrically and are presented in the table (n=3). The graphic shows
SUMO1/2-AMC hydrolysis catalyzed by control HeLa cell extracts (37 °C; black lines),
and by heat-shocked HeLa cell extracts (43 °C; grey lines). B) Rat liver nuclei proteins
SUMO2ylated in vitro (see Section 2. Materials and methods; lane –, 100% input)
were incubated at 37 °C with different amounts of total homogenates from HeLa cells
(100, 200 or 400 μg) grown at 37 °C or heat-shocked at 43 °C, as indicated, and
processed for SDS-PAGE/Western blot using an anti-SUMO2/3 antibody. Positive
(lane cSP1; containing 250 ng of cSENP1) and negative control reactions (lane S2ald;
containing SUMO2-aldehyde and 400 μg of HeLa extracts) were also analyzed. Numbers
at the bottom of the upper panel represent relative amounts of SUMO2 conjugates
remaining at the end of the incubation, as determined by densitometric analysis of
total lanes. The amount of conjugates present in lane – was set to 100%. A section of
the Ponceau S-stained membrane is presented in the lower panel. Numbers to the left
indicate the molecular masses of protein standards in kilodaltons.
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treatment with 5 mM iodoacetamide and the excess of alkylating
agent was then neutralized with 10 mM DTT. The in vitro
SUMOylated proteins were then incubated with total extracts from
control or heat-shocked HeLa cells for 30 min at 37 °C in the presence
of 2 mM AMP and 0.15 mM sodium pyrophosphate to prevent any de
novo SUMOylation. Where indicated, reactions also received 250 ng
of cSENP1 or 0.5 μM SUMO2-aldehyde. All reactions were stopped
with 10 mM NEM, incubated for 5 min on ice and analyzed by
SDS-PAGE/Western blot using an anti-SUMO2/3 antibody [60].
2.5. Covalent labeling with HA-tagged SUMO/Ub-VME probes
Labeling reactions were performed at 25 °C for 15 min with 200 μg
of HeLa cell total extracts, or 0.5 μl of 35S-labeled SENPs, or 50 ng of the
recombinant catalytic domains in 20 μl of SEM buffer supplemented
with 1 mM DTT, in the presence of 100 ng of HA-SUMO1/SUMO2/
Ub-VME. Some reactions were preincubated with 500 ng of the respec-
tive aldehyde analogue for 5 min at 25 °C before adding the VME
probes. Where indicated, samples were treated with 60 ng of cSENP1
for 15 min at 25 °C before addition of the VME probe. Reactions were
terminated with Laemmli sample buffer.
2.6. Antibodies
Rabbit polyclonal antibodies against SENPs were kindly provided by
Dr. Mary Dasso [33,35,61]. The mouse monoclonal anti-SUMO1 (21C7)
[7] and anti-SUMO2/3 (8A2) [60] antibodies developed by Michael J.
Matunis were obtained from the Developmental Studies Hybridoma
Bank developed under the auspices of the NICHD and maintained by
the University of Iowa, Department of Biology, Iowa City, IA 52242.
Mouse monoclonal anti-HA (16B12) and anti-His were purchased from
Covance and GE Healthcare, respectively. Primary antibodies were
detected on Western blots with alkaline phosphatase-conjugated
anti-rabbit or anti-mouse IgGs (Sigma). Densitometric analyses of West-
ern blots were performed using the ImageJ software (Rasband, W.S.,
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA,
http://imagej.nih.gov/ij/, 1997–2011).
2.7. Fluorescence-based denaturation assays
Denaturation assays were performed in 25 μl of 50 mM Tris–HCl,
pH 8.0, 150 mM NaCl, 10% (w/v) glycerol and 10 mM DTT, containing
1 μM cSENP1/2/5–7 and 5× SYPRO Orange dye (Sigma, stock solution
5000×) in a iQ5 Real Time Detection System (Bio-Rad) using 96 well
PCR plates. For differential scanning ﬂuorimetry, the samples were
heated from 20 to 85 °C with a ramping rate of 1 °C/min and ﬂuores-
cence monitoring every 0.5 °C. The scan curves were ﬁtted to a
Boltzmann sigmoid function using GraphPad Prism 5 software and
the apparent melting temperatures (Tm) were obtained from the tem-
perature midpoint of the protein unfolding transition, as described
[62,63]. To monitor cSENP denaturation at 43 °C over time, the plates
were ﬁrst heated for 5 min at 37 °C, followed by 30 min at 43 °C and
5 min at 70 ºC, with ﬂuorescence reading every 30 s. All experiments
were performed at least in triplicate.
3. Results and discussion
To address the possible contribution of SENPs to the heat
shock-induced accumulation of SUMO conjugates, we determined
the activity of these proteases in total homogenates from HeLa cells
subjected or not to heat shock treatment. Three different assays
were used for this purpose. In the ﬁrst, we measured total SENP activ-
ity using two ﬂuorogenic substrates, SUMO1-AMC and SUMO2-AMC
[35,55]. These SUMO1/2 derivatives carry an AMC moiety at their C
terminus which ﬂuoresces upon hydrolysis by SENPs. As shown inFig. 1A, homogenates from cells treated at 43 °C for 30 min display
62 and 29% of the activity found in control cells when assayed with
SUMO1-AMC and SUMO2-AMC, respectively.
In the second assay, we incubated HeLa cell homogenates with in
vitro synthesized SUMO2 conjugates (see Section 2 Materials and
methods for details) and monitored the decrease of these conjugates
by SDS-PAGE/Western blot using an anti-SUMO2/3 antibody [60]. The
result obtained, although of qualitative nature, suggests that SENP ac-
tivity is decreased by heat shock treatment (see Fig. 1B).
Finally, the levels of active SENPs in heat-shocked and control cells
were assessed by incubating total cell homogenates with VME-
derivatized HA-tagged SUMO1 or SUMO2 [55]. These activity-based
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valently linked SUMO-SENP products. These products can then be
detected by SDS-PAGE/Western blot using an anti-HA antibody. As
shown in Fig. 2A, several protein bands were detected in homoge-
nates labeled with the HA-SUMO1/2-VME probes (asterisks in lanes
2 and 8, respectively). None of these bands was detected when the la-
beling reactions were performed in the presence of a vast excess of
SUMO1-aldehyde (lane 3) or SUMO2-aldehyde (lane 9), two other
potent inhibitors of SENPs that compete with the VME probes for
SENPs catalytic domains [55]. Thus, the species detected in these ex-
periments represent active SENPs. In agreement with the results of
the two assays described above, the intensities of several HA-
SUMO1/2-VME-labeled SENPs were decreased in homogenates from
HeLa cells heat-shocked for 30 min (Fig. 2A; compare lanes 2 and
8with lanes 5 and 11, respectively). Attempts to recover SENP activity
by incubating cell homogenates for 1 h at 25 °C or 37 °C before label-
ing reactions with the SUMO-VME probes were not successful (data
not shown), suggesting that heat shock-induced inactivation of
SENPs is an irreversible process (see also below). Importantly, treat-
ment of homogenates from heat-shocked cells with the recombinantFig. 2. HA-SUMO1/2-VME labeling of SENPs in HeLa cells. A) Total extracts from HeLa cell
HA-SUMO2-VME and analyzed by SDS-PAGE/Western blot using the anti-HA antibody to
Some samples were pre-incubated with an excess of SUMO1-aldehyde or SUMO2-aldehyd
conjugates. B) Total homogenates from HeLa cells heat-shocked for 30 min were incubate
half was treated with HA-SUMO1-VME whereas the other was treated with HA-SUMO2-
anti-HA antibody to detect active SENPs (upper panel) or using anti-SUMO1 (anti-S1) or a
asterisk indicates the cSENP1-SUMO1/2-VME adducts. C) Same as in A but using HA-Ub-VM
molecular masses of protein standards in kilodaltons.catalytic domain of SENP1 (cSENP1) prior to incubation with
HA-SUMO1/2-VME leads to the disappearance of all SUMO2/3 conju-
gates, and nearly all SUMO1 conjugates (Fig. 2B, lower panel), as
expected [64], but does not result in an increase in the labeling inten-
sity of SENPs by the VME probes (Fig. 2B, upper panel). Thus, the heat
shock-induced decrease in SENPs activity, as assessed with the VME
probes, is not due to a competition effect exerted by endogenous
SUMO protein conjugates. Taken together, these data suggest that a
30 min heat shock decreases the activity of several SENPs.
Interestingly, treatment of total cell homogenates with HA-tagged
ubiquitin-VME (HA-Ub-VME), an activity-based probe that reacts
with deubiquitinases belonging to the cysteine protease family [54]
did not reveal signiﬁcant differences between control and heat-
shocked cells (see Fig. 2C). This ﬁnding suggests that the SENP sub-
family of cysteine proteases is particularly enriched in heat shock-
sensitive members.
Heat shock induced accumulation of SUMO2/3 conjugates is a
quite fast event, reaching a maximum after just 5 min of hyperther-
mic stress [10,43]. In contrast, the decrease in the levels of these con-
jugates in HeLa cells that were heat-shocked at 43 °C for 30 min ands subjected or not to heat shock for 30 min were incubated with HA-SUMO1-VME or
detect labeled SENPs. A portion of the Ponceau S-stained membrane is also shown.
e before adding the VME probe, as indicated. The asterisks mark HA-SUMO1/2-SENP
d in the absence (−) or presence (+) of cSENP1. The samples were halved and one
VME. Aliquots of these samples were subjected to SDS-PAGE/Western blot using an
nti-SUMO2/3 (anti-S2/3) to detect endogenous SUMO conjugates (lower panels). The
E and Ub-aldehyde instead of the SUMO derivatives. Numbers to the left indicate the
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only after 2 h of incubation at 37 °C do the levels of SUMO2/3 conju-
gates return to their pre-heat shock values [43]. To assess whether
SENP activity is somehow correlated with the kinetics of these two
events we monitored the levels of SUMO conjugates and active SENPs
at different time points during the heat shock and recovery incubations.
As shown in Fig. 3A, the massive accumulation of SUMO2/3 conjugates
observed after just 5 min of heat shock is accompanied by a small, but re-
producible, reduction (10–15%, range of three determinations) in theFig. 3. Levels of active SENPs and SUMO conjugates during heat shock and recovery at
37 °C. A) HeLa cells were subjected to heat shock treatment for the indicated periods of
time. At each time point two aliquots were withdrawn which received or not 10 mM
NEM (upper panels and lower panel, respectively). Total cell lysates prepared in the
presence of NEM were processed for SDS-PAGE/Western blot analyses with the
anti-SUMO1 or anti-SUMO2/3 antibodies (anti-S1 or anti-S2/3, respectively; upper
panels). Samples prepared in the absence of NEM were incubated with HA-SUMO1-
VME or HA-SUMO2-VME and analyzed by SDS-PAGE/Western blot using the anti-HA
antibody (lower panel). B) HeLa cells were kept at 37 °C or subjected to heat shock
for 30 min at 43 °C (lanes 37 °C and 43 °C, respectively). Heat-shocked cells were
then allowed to recover at 37 °C for the indicated periods of time, either in the absence
(−) or presence of cycloheximide and puromycin (CHX/P), to block protein synthesis.
At each time point two aliquots were withdrawn and processed as above. SUMO2/3
conjugates are shown in the upper panel. HA-SUMO2-VME-reactive SENPs are shown
in the lower panel. The levels of SUMO2/3 conjugates and VME-labeled SENPs at each
time point were determined by densitometry and are indicated at the bottom of each
panel. The levels of SUMO2/3 conjugates in lane 43 °C and of labeled SENPs in lane
37 °C were set to 100%. Numbers to the left indicate the molecular masses of protein
standards in kilodaltons.overall intensity of HA-SUMO1/2-VME-reactive bands. A similar inverse
correlation between the levels of SUMO2/3 conjugates and the intensi-
ties of some VME-reactive bands was observed during the 37 °C recov-
ery incubation. Indeed, as shown in Fig. 3B, the decrease in the levels of
SUMO2/3 conjugates during this incubation (upper panel) paralleled a
slight increase in the intensity of some VME-reactive bands (lower
panel). This increase is probably the result of protein synthesis because
it was not observed when cells were incubated at 37 °C in the presence
of protein synthesis inhibitors. Under these conditions, considerable
amounts of SUMO2/3 conjugates were still detectable after 6 h of incu-
bation. Although the changes in the two parameters monitored in these
experiments are of different magnitudes (see Section 4. Conclusion), al-
together these results suggest that there is an inverse correlation be-
tween SENP activity and the levels of SUMO2/3 conjugates.
The decrease in SENP activity observed upon heat shock could re-
sult from a decrease in protein levels (e.g., some SENPs might be sim-
ply degraded) or from a diminished speciﬁc activity. To discriminate
between these two possibilities, total homogenates from control or
heat-shocked (30 min) cells, treated or not with HA-tagged SUMO1/
2-VME, were analyzed by Western blot using SENP-speciﬁc anti-
bodies. We note that many of these antibodies recognize multiple pro-
teins in these blots. However, comparison of the band patterns obtainedFig. 4. Several SENPs are inactivated by heat shock. Total extracts from control (37 °C)
or heat-shocked (43 °C) HeLa cells were incubated in the absence (−) or in the pres-
ence of HA-tagged SUMO1-VME or SUMO2-VME, as indicated. Samples were analyzed
by SDS-PAGE/Western blot using either SENP-speciﬁc antibodies (ﬁve upper panels) or
anti-HA antibody (bottom panel). Unmodiﬁed SENPs (SENP) as well as their VME ad-
ducts (SENP′) are indicated. Note that SENP2 displays an apparent molecular mass of
50 kDa and probably corresponds to the most abundant isoform in HeLa cells, as de-
scribed recently [35,68]. Densitometric analyses of Western blots probed with the
anti-HA antibody revealed that SENP1 and SENP3 are inactivated upon heat shock by
~60% and ~80%, respectively. Numbers to the left indicate the molecular masses of pro-
tein standards in kilodaltons.
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us to unambiguously identify protein bands corresponding to SENP1–
3/6–7. Efforts to detect SENP5 in HeLa extracts using three different an-
tibodies were not successful thus far. The results of these analyses are
shown in Fig. 4. For all analyzed SENPs, no signiﬁcant differences in
their steady-state levels were detected between control and
heat-shocked cells (Fig. 4, compare lanes 1 and 2). Thus, the heat
shock-induced decrease in SENP activity probably results from a de-
crease in the speciﬁc activity of these proteases. The results obtained
with the HA-SUMO1/2-VME-treated samples corroborate this interpre-
tation and allowed us to identify the heat shock-sensitive SENPs. As
shown in Fig. 4 (compare lanes 3 and 5with 4 and 6, respectively), pro-
tein bands corresponding to adducts between the SUMO probes and
SENP1–3/7 are either undetectable (SENP2/7) or largely decreased
(SENP1, ~60% decrease; SENP3, ~80% decrease) in homogenates from
cells subjected to heat shock. The exception is SENP6, whichwas not af-
fected by the heat shock treatment at all.
The data presented in Fig. 4 also allow us to draw some conclu-
sions regarding SENP relative abundances in HeLa cells as well as
the reactivity of these proteases towards the HA-SUMO1/2-VME
probes. Side-by-side alignment of the blots shown in Fig. 4, together
with the behavior of each SENP regarding its reactivity with the elec-
trophilic probes and its sensitivity to heat shock, allowed us to corre-
late each of the protein bands detected with the anti-HA antibody
(bottom panel) with a speciﬁc SENP. This correlation suggests the fol-
lowing order in SENP abundance: SENP3>SENP1>SENP2~SENP6.
No protein bands corresponding to SENP7 and SENP5 were detected
in blots probed with the anti-HA antibody (Fig. 4, bottom panel),
suggesting that these two proteins are the least abundant SENPs. Re-
garding the reactivity of the different SENPs with HA-SUMO1/2-VME
probes, and in agreement with previous data [22,26,27,29,34,35], we
found that SENP2, SENP3 and SENP7 display a bias towards reactingFig. 5. Heat sensitivity of in vitro synthesized SENPs and their recombinant catalytic domain
43 °C. The samples were then treated with HA-SUMO1-VME or HA-SUMO2-VME for 15 min
their adducts with the VME probes (SENP′) are indicated. Lane I, untreated 35S-labeled SENP
43 °C as above and subjected to labeling reactions with HA-SUMO1-VME or HA-SUMO2-VME
catalytic domains (cSENP) and their adducts with the VME probes (cSENP′) are indicated. La
ular masses of protein standards in kilodaltons.with the HA-SUMO2-VME probe whereas SENP1 reacts equally well
with both HA-SUMO1/2-VME probes. Similarly to SENP1, SENP6 re-
acts with both HA-SUMO1/2-VMEwith no apparent preference for ei-
ther probe. This ﬁnding is in slight disagreement with previous
reports showing that SENP6 reacts better with SUMO2-vinyl sulfone
than with SUMO1-vinyl sulfone [33,35]. The fact that the SUMO
probes used here contain a vinyl methyl ester, a chemical group
that may be more reactive than the vinyl sulfone moiety [54], may ex-
plain this discrepancy.
The decrease in the speciﬁc activities of SENP1–3/7 observed upon
heat shockmay result from an extrinsic regulatory mechanism (e.g., in-
teractionswith unknown regulatory proteins) and/ormay reﬂect an in-
trinsic property of these proteases. Whereas addressing the ﬁrst
hypothesis would require detailed knowledge on the protein interac-
tion network of each SENP, we reasoned that the second hypothesis
could be easily put to the test. For this purpose, we synthesized all
human SENPs using an in vitro transcription/translation system, and
after subjecting these proteins to a 37 °C or 43 °C incubation, we
assessed their activity using the HA-SUMO1/2-VME probes. As shown
in Fig. 5A, there is a good correlation between the behavior of each
SENP in this in vitro assay and that of the endogenous proteases in
heat-shocked or control cells (Fig. 4). Thus, again with the exception
of SENP6, all other SENPs, including now also SENP5, are at least partial-
ly inactivated by heat treatment.
Identical experiments were performed using bacterial-expressed
recombinant proteins comprising the catalytic domains of SENP1/2/
5–7 (cSENP1/2/5–7; the catalytic domain of SENP3 is presently not
available). As shown in Fig. 5B, and in agreement with previous data
[35], cSENP2/5–7 no longer display a preference for the SUMO2-
based probe, reacting equally well with both SUMO1/2 probes. As
proposed previously, SENP domains not present in these recombinant
proteins may play a role in SUMO selectivity [35]. Importantly, alls. A) 35S-labeled SENPs were synthesized in vitro and incubated for 30 min at 37 °C or
at 25 °C and analyzed by SDS-PAGE/Western blot/autoradiography. SENPs (SENP) and
used in each reaction. B) Recombinant His-tagged cSENPs were preincubated at 37 °C or
. Samples were subjected to SDS-PAGE/Western blot using an anti-His antibody. SENPs
ne I, recombinant cSENPs used in each reaction. Numbers to the left indicate the molec-
1964 M.P. Pinto et al. / Biochimica et Biophysica Acta 1823 (2012) 1958–1966these recombinant proteins but one, the catalytic domain of SENP6,
are extensively (cSENP1) or totally (cSENP2/5/7) inactivated by the
43 °C incubation.
Attempts to recover the activity of these recombinant proteins by in-
cubating them at 25 °C or 37 °C before performing the labeling reac-
tions with the SUMO-VME probes were not successful (data not
shown). This ﬁnding suggests that inactivation of these proteins by
heat treatment is irreversible, probably the result of a denaturation
event. To address this possibility we characterized the thermal stability
of cSENPs using a ﬂuorescence-based assay [62,63]. The assay explores
the fact "that folded and unfolded proteins can be distinguished
through exposure to a hydrophobic ﬂuoroprobe" [62]. The ﬂuoroprobe,
in our case the SYPRO Orange dye, binds to protein hydrophobic do-
mains that become exposed during heat-induced unfolding with a con-
comitant increase in its ﬂuorescence emission. We ﬁrst determined the
apparentmelting temperatures of cSENPs. As shown in Fig. 6A, cSENP1/
2/5/7 present quite similar apparent melting temperatures ranging
from 44.5 to 48.5 °C. In contrast, a much higher apparent melting tem-
perature was determined for cSENP6 (55.6 °C), suggesting that this cat-
alytic domain is much more resistant to heat-induced denaturation
than the other cSENPs. A similar conclusion was obtained in a time
course analysis of denaturation performed at 43 °C (Fig. 6B). In contrast
to cSENP6 which was marginally affected by the 43 °C treatment, the
other proteins were partially (cSENP1) or completely (cSENP2/5/7) de-
natured under these conditions, in good agreement with the dataFig. 6. Thermal unfolding of the recombinant catalytic domains of SENPs. A) Recombi-
nant cSENP1/2/5–7 were analyzed by differential scanning ﬂuorimetry in the presence
of SYPRO Orange dye. The apparent melting temperatures (Tm) obtained from the scan
curves are indicated in the table. B) Recombinant cSENPs were incubated in the pres-
ence of SYPRO Orange dye for 5 min at 37 °C, followed by 30 min at 43 °C and, ﬁnally,
5 min at 70 °C. Fluorescence was monitored throughout the incubation time. Fluores-
cence intensities were normalized to a maximum of 1 and a minimum of 0. Represen-
tative curves for each cSENP are shown.shown in Fig. 5B. Taken together these data suggest that the
heat-induced inactivation of cSENP1/2/5/7 is due to an irreversible de-
naturation event.
The sensitivity of SENPs to a 43 °C incubation was also observed
with endogenous HeLa SENPs using a coupled SUMOylation/
deSUMOylation in vitro assay. In the experiment shown in Fig. 7A, a ho-
mogenate from HeLa cells grown at 37 °C was incubated at 37 °C or
43 °C for 15 min in a buffer containing recombinant SUMO2 and ATP.
Robust amounts of SUMO2 conjugates were accumulated at 37 °C, but
only when SENPs were inhibited with SUMO2-aldehyde (Fig. 7A, com-
pare lanes 2 and 3). Thisﬁnding suggests that endogenous SENPs hydro-
lyze most of the SUMO2 conjugates synthesized in this assay at 37 °C. A
different result was obtained at 43 °C. Indeed, whereas the amounts of
SUMO2 conjugates obtained at 37 °C and 43 °C in the presence of
SUMO2-aldehydewere indistinguishable (Fig. 7A, lanes 3 and 5, respec-
tively), the amounts of SUMO2 conjugates obtained in the absence of
the SENP inhibitor were now much larger at 43 °C than at 37 °C (com-
pare lanes 2 and 4). Apparently, the activity of the SENP(s) that hydro-
lyzes most of the SUMO2 conjugates at 37 °C was largely decreased at
43 °C. In agreement with this interpretation, analyses of HeLa cell
homogenates that were pre-treated for 15 min at 37 or 43 °C and
then incubated with the HA-SUMO1/2-VME probes revealed a signiﬁ-
cant inactivation of SENPs at 43 °C (Fig. 7B).4. Conclusion
Mammalian cells andmany different organisms respond to several
stress stimuli by accumulating massive amounts of SUMO conjugates
[9,10,39,40]. The mechanisms behind these responses are still ill-
deﬁned, but in at least two cases data suggesting the involvement of
SENPs in this phenomenon have been provided. One regards the ac-
cumulation of SUMO conjugates in mammalian cells exposed toFig. 7. Endogenous HeLa SENPs are heat-sensitive in vitro. A) A homogenate from HeLa
cells grown at 37 °C (200 μg per lane) was incubated for 15 min at 37 °C or 43 °C in a
buffer containing recombinant SUMO2 and ATP, either in the presence (+) or absence
(−) of SUMO2-aldehyde. Samples were analyzed by SDS-PAGE/Western blot using the
anti-SUMO2/3 antibody (anti-S2/3). Lane I, 200 μg of the HeLa cell lysate used in the in
vitro reactions. B) A homogenate from HeLa cells grown at 37 °C and incubated as
above was treated with either HA-SUMO1-VME or HA-SUMO2-VME. A Western blot
using the anti-HA antibody is presented. SENP-SUMO1/2-VME adducts are indicated
(SENP′). Numbers to the left indicate the molecular masses of protein standards in
kilodaltons.
1965M.P. Pinto et al. / Biochimica et Biophysica Acta 1823 (2012) 1958–1966very high concentrations of hydrogen peroxide. Under these condi-
tions SENPs are inactivated due to the formation of intra- or inter-
molecular disulﬁde bridges [39,65,66]. The second example regards
Saccharomyces cerevisiae Ulp1, a SUMO-speciﬁc protease that is nor-
mally found in the nuclear pore complex but that is targeted to and
sequestered in the nucleolus in response to alcohol stress [67].
In thisworkwe addressed thepossibility that SENPs could also play a
role in the heat shock-induced accumulation of SUMO2/3 protein conju-
gates. The speciﬁc hypothesis tested here was that the activities of these
proteases could be decreased by this type of stress. The data obtained
indicate that the activities of at least themost abundant SENPs progres-
sively decrease during hyperthermic stress, thus suggesting that these
proteases play a role in the accumulation of SUMO2/3 conjugates. Natu-
rally, in the absence of data describing how tightly linked is SENP activ-
ity to the homeostasis of SUMO2/3 conjugates, the magnitude of the
impact of the decreased SENP activity described in this work on the
steady-state concentration of SUMO2/3 conjugates cannot be presently
quantiﬁed. Furthermore, the steady-state levels of SUMO2/3 conjugates
also depend on the activity of the SUMO-conjugation cascade and
whether or not its activity changes during heat shock remains to be de-
termined. Regardless, the heat shock-induced inactivation of SENPS
should minimize futile SUMO conjugation/deconjugation cycles and
thus, at the very least, should provide an advantage in the adaptation
of cells to this stress condition.
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